NCT04321980View on ClinicalTrials.gov

A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 19, 2020

Primary Completion Date

May 22, 2020

Study Completion Date

May 22, 2020

Conditions
Healthy
Interventions
DRUG

OP-101

Subcutaneous injection of OP-101 in healthy volunteers

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors

Lead Sponsor

Orpheris, Inc.
All Listed Sponsors
lead

Orpheris, Inc.

INDUSTRY